Literature DB >> 827024

Chemotherapy of ovarian cancer: past and present.

R C Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 827024

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  13 in total

Review 1.  Chemotherapy in the management of ovarian carcinoma: a review.

Authors:  J S Malpas
Journal:  J R Soc Med       Date:  1979-05       Impact factor: 5.344

2.  Oat cell carcinoma mimicking acute leukemia.

Authors:  R Taetle; H Wohl
Journal:  West J Med       Date:  1978-12

3.  Process and outcome of care for patients with ovarian cancer.

Authors:  A Liberati; C Mangioni; L Bratina; G Carinelli; S Marsoni; F Parazzini; M Regallo; R Talamini; G Tognoni
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

Review 4.  Treatment of ovarian cancer: the state of the art.

Authors:  N Einhorn
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

Review 5.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 6.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

7.  The staging and treatment of epithelial ovarian cancer.

Authors:  R C Young; R I Fisher
Journal:  Can Med Assoc J       Date:  1978-08-12       Impact factor: 8.262

8.  Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Authors:  D S Alberts; H S Chen; S E Salmon; E A Surwit; L Young; T E Moon; F L Meyskens
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

9.  Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.

Authors:  C Sessa; G Bolis; N Colombo; M D'Incalci; B Mermillod; I Valente; C Mangioni
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Major clinical research advances in gynecologic cancer 2008.

Authors:  Kidong Kim; Seok-Cheol Choi; Sang-Young Ryu; Jae Weon Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.